Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as Indications for MSP-1014, its NoveHow Will The Data Protection Ruling On Ketamine Impact Psychedelic Novel Drug Development Moving Forward?Mindset Pharma Announces its Next Generation Novel 5-MeO-DMT Psychedelic AnalogsSilo Pharma Advances Psychedelic Patent PortfolioTryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of FloridaMajor Psychedelic Clinical Trial Data Is Right Around The CornerPsychedelic Drug Development Companies Are Leveraging Bolt On MedTech Acquisitions To Create A More Robust Patient Care 7 Psychedelic Clinical Trials Underway That Investors Should Keep On Their RadarNuminus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into PSilo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide PatentTryp Therapeutics Announces Q3 2021 Financial ResultsKetamine One’s IRP Clinic Using Innovative NeuroCatch Platform to Measure Brain Function in Injured VeteransWake Network, Inc. and the Lieber Institute for Brain Development Announce Research CollaborationTryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of MichiganNuminus Wellness Reaches Major Milestone With MAPS Sponsored MDMA StudyNuminus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSDPsyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative Care Clinical TrialTryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary FormulationsPsyched Wellness Commences Next Pre-Clinical Study on AME-1Atai Life Sciences Is Setting The Standard For Psychedelic Drug Development

Technical420 Site Search

Returned 19 result(s).

How Will The Data Protection Ruling On Ketamine Impact Psychedelic Novel Drug Development Moving Forward?

Last month, Canada’s Federal Court of Appeals passed a decision from the Ministry of Health to provide a subsidiary of Johnson and Johnson (NYSE: JNJ) data protection for Spravato, a ketamine treatment that has been approved for depression. The drug is the first ketamine treatment to be approved to treat…

Organigram Receives Health Canada Approval for an Additional 17 Cultivation Rooms in Phase 4A

Organigram Holdings Inc. (OGI) (OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that it has received approval from Health Canada for the licensing of 17 additional cultivation rooms within the Phase 4A/ 4B perimeter of the building. Thirteen…

Canopy Growth subsidiary and Canopy Rivers portfolio company Vert Mirabel now fully licensed by Health Canada

Les Serres Vert Cannabis Inc., a subsidiary of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and a portfolio company of Canopy Rivers Inc. (TSXV: RIV) (OTC: CNPOF) has received its final cultivation licence from Health Canada. All 700,000 sq. ft. of operating space at Vert Mirabel is now licensed for…

Emerald Health Therapeutics Announces Pure Sunfarms’ Receipt of Standard Processing License for Delta 3 Greenhouse Facility

Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) today announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has received a Standard Processing License (the “Processing License”) from Health Canada for its 1.1 million square foot Delta 3 greenhouse facility. The Processing License permits Pure…

CannTrust Receives Health Canada Approval for Phase 2 Expansion

CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX:TRST, NYSE:CTST) is pleased to announce that its cultivation and processing permit under Health Canada Cannabis Regulations was amended to include the final 20% of its Phase 2 expansion. The entire 450,000 sq. ft. of its perpetual harvest greenhouse in Pelham, Ontario, is…

High Park Farms™ Receives Cannabis Sales License from Health Canada

High Park Farms™ Ltd., a subsidiary of Tilray, Inc. (TLRY), announced today that it has received its sales license from Health Canada to sell cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The license will allow High Park Farms to supply and sell finished cannabis products within the ACMPR…

Health Canada grants Cannabis Cultivation Licence to BlissCo

BlissCo Cannabis Corp. (CSE: BLIS) ("BlissCo" or the "Company") is pleased to announce that the Company's wholly-owned subsidiary, Bliss Co Holdings Ltd. ("BlissCo") has been granted a licence by Health Canada to cultivate cannabis plants and prepare dried cannabis."Earning our ACMPR Licence to cultivate cannabis plants from Health Canada represents…

Invictus MD to Increase Investment in AB Laboratories; AB Laboratories Receives Sales License; AB Laboratories, AB Ventures and Acreage Pharms Target over 26,000 kg Capacity in 2018

INVICTUS MD STRATEGIES CORP. (TSXV: IMH; OTC: IVITF; FRA: 8IS1) is pleased to announce that the Company has entered into a Letter of Intent ("LOI") to make a further strategic investment in the licensed production facility under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"), AB Laboratories Inc. ("AB…

Veritas Pharma Subsidiary Receives Health Canada Dealer Licence

Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF), announces that Health Canada has issued its research and development subsidiary, Cannevert Therapeutics Ltd. a dealer licence no. 2018/6970 under Health Canada’s Section 9.2 of the Narcotic Control Regulations that will allow them to possess, produce, analyze, sale, send, transport, and deliver cannabis, hemp and…

7 Canadian Cannabis Stocks With No Signs Of Slowing Down

Canadian cannabis stocks continue to be one of the most attractive places to invest and pullbacks like the one we saw yesterday create great opportunities for new investors.While the weakness was significant, it was necessary and Mushroomstocks Premium Members capitalized on this. The recent rally has been incredible and pullbacks…

Older Posts »

Search Again

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link